Stipple Bio
Biotechnology company unlocking cellular profiling and target discovery with epitope resolution, using proprietary epitope-level resolution technology to enable single-cell profiling and drug target discovery.
Website
https://www.stipplebio.comLocation
Boston, Massachusetts, USA
Founded
2021
Investors
1
Categories
single-cell, target-discovery, epitope-mapping, biotech, proteomics
Notes
Stipple Bio is a biotechnology company focused on unlocking cellular profiling and target discovery with epitope resolution. The company uses proprietary epitope-level resolution technology to enable single-cell profiling and target discovery.
The company's technology provides unprecedented resolution in understanding protein expression at the single-cell level, enabling:
- Identification of novel drug targets
- Understanding of cellular heterogeneity
- Epitope-level characterization of protein expression
- Applications in drug discovery and development
By providing epitope-level resolution, Stipple Bio's platform can reveal subtle differences in protein expression and conformation that traditional methods miss.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Epitope-level resolution technology
- Single-cell profiling capabilities
- Target discovery platform
- Drug discovery applications
- Boston, Massachusetts headquarters
- Founded in 2021
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |